PTGX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

13.59

Margin Of Safety %

-32

Put/Call OI Ratio

0.38

EPS Next Q Diff

0.07

EPS Last/This Y

6.52

EPS This/Next Y

-4.66

Price

145.99

Target Price

152.14

Analyst Recom

1.21

Performance Q

47.57

Upside

-90.7%

Beta

1.79

Ticker: PTGX

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-14	PTGX	131.39	0.47	0.88	7954
2026-07-15	PTGX	136.2	0.47	1.53	7989
2026-07-16	PTGX	132.18	0.47	0.05	8008
2026-07-17	PTGX	141.03	0.47	0.06	8003
2026-07-20	PTGX	133.83	0.38	2.21	6126
2026-07-21	PTGX	138.19	0.39	0.00	6150
2026-07-22	PTGX	135.35	0.39	0.02	6147
2026-07-23	PTGX	135.26	0.34	0.00	6816
2026-07-24	PTGX	136.21	0.31	0.67	7463
2026-07-27	PTGX	135.63	0.31	0.00	7489
2026-07-28	PTGX	136.78	0.31	0.08	7590
2026-07-29	PTGX	132.78	0.31	0.33	7600
2026-07-30	PTGX	138.61	0.31	0.06	7615
2026-07-31	PTGX	136.85	0.31	0.15	7592
2026-08-03	PTGX	132.4	0.31	3.83	7612
2026-08-04	PTGX	136.63	0.31	0.83	7645
2026-08-05	PTGX	137.52	0.32	47.00	7672
2026-08-07	PTGX	146	0.38	1.59	8229
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-14	PTGX	131.41	422.5	-	4.19
2026-07-15	PTGX	135.56	422.5	-	4.19
2026-07-16	PTGX	132.04	422.5	-	4.19
2026-07-17	PTGX	140.91	422.5	-	4.19
2026-07-20	PTGX	134.02	422.4	-	4.19
2026-07-21	PTGX	138.22	424.4	-	4.21
2026-07-22	PTGX	135.55	424.4	-	4.21
2026-07-23	PTGX	135.36	450.7	-	4.47
2026-07-24	PTGX	136.26	450.7	-	4.47
2026-07-27	PTGX	135.63	450.7	-	4.47
2026-07-28	PTGX	136.72	450.7	-	4.47
2026-07-29	PTGX	132.78	450.7	-	4.47
2026-07-30	PTGX	138.73	450.7	-	4.47
2026-07-31	PTGX	136.82	450.7	-	4.47
2026-08-03	PTGX	132.24	450.7	-	4.47
2026-08-04	PTGX	132.24	450.7	-	4.47
2026-08-05	PTGX	137.54	450.7	-	4.47
2026-08-06	PTGX	146.32	450.7	-	4.47
2026-08-07	PTGX	145.99	450.7	-	4.47
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-14	PTGX	-12.99	12.83	12.60
2026-07-15	PTGX	-12.99	12.83	12.60
2026-07-16	PTGX	-12.99	12.83	12.60
2026-07-17	PTGX	-12.99	12.83	12.60
2026-07-20	PTGX	-12.99	12.90	12.60
2026-07-21	PTGX	-12.99	12.90	12.60
2026-07-22	PTGX	-11.76	12.90	12.60
2026-07-23	PTGX	-11.76	12.90	12.60
2026-07-24	PTGX	-11.76	12.90	12.60
2026-07-27	PTGX	-11.76	12.90	13.59
2026-07-28	PTGX	-8.87	12.90	13.59
2026-07-29	PTGX	-8.87	12.90	13.59
2026-07-30	PTGX	-8.87	12.90	13.59
2026-07-31	PTGX	-8.87	12.90	13.59
2026-08-03	PTGX	-8.87	13.79	13.59
2026-08-04	PTGX	-8.87	13.79	13.59
2026-08-05	PTGX	-8.87	13.79	13.59
2026-08-06	PTGX	-8.87	13.79	13.59
2026-08-07	PTGX	-8.36	13.79	13.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

2.29

Avg. EPS Est. Current Quarter

1.93

Avg. EPS Est. Next Quarter

2.36

Insider Transactions

-8.36

Institutional Transactions

13.79

Beta

1.79

Average Sales Estimate Current Quarter

211

Average Sales Estimate Next Quarter

214

Fair Value

99.55

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

1.4

Max Drawdown 5-Year %

-85.8

Target Price

152.14

P/E

140.65

Forward P/E

PEG

P/S

33.47

P/B

11.21

P/Free Cash Flow

72.29

EPS

1.04

Average EPS Est. Cur. Y

4.47

EPS Next Y. (Est.)

-0.19

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

29.4

Relative Volume

0.46

Return on Equity vs Sector %

-17.5

Return on Equity vs Industry %

-1.4

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.29

EBIT Estimation

◆ PTGX Healthcare

$145.87

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

8/25

Volume

11/15

Valuation

3/20

TP/AR

4/10

Options

5/10

RSI

64.8

Range 1M

91%

Sup Dist

3.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

13/25

Growth

21/30

Estimates

4/20

Inst/Vol

9/15

Options

7/10

EPS Yr

319%

EPS NY

-111.1%

52W%

97.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -17.4% upside

Quality

9/30

Valuation

2/30

Growth

15/25

Stability

8/10

LT Trend

4/5

Upside

-17.4%

Quality

MoS

-32%

PTGX — P/E HistoricalBiotechnology

Protagonist Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 141

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

PTGX

Latest News

—

Caricamento notizie per PTGX…

stock quote shares PTGX – Protagonist Therapeutics Inc Stock Price stock today

news today PTGX – Protagonist Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch PTGX – Protagonist Therapeutics Inc yahoo finance google finance

stock history PTGX – Protagonist Therapeutics Inc invest stock market

stock prices PTGX premarket after hours

ticker PTGX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PTGX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y